Literature DB >> 7851197

Colonic lactate metabolism and D-lactic acidosis.

H Hove1, P B Mortensen.   

Abstract

D-Lactic acidosis is seen in patients with intestinal bypass or short bowels in whom colonic produced D-lactate accumulates. An intestinal bypassed patient with D-lactic acidosis had higher fecal D-lactate (122.4 mmol/liter) and L-lactate (90.1 mmol/liter) than described before in humans. D-Lactate fluctuated between 0.5 and 3.1 mmol/liter in plasma (normal < 0.1 mmol/liter) and between 1.1 and 52.8 mmol/liter in urine (normal < 0.7 mmol/liter) within a few hours, indicating that the human organism do metabolize and excrete D-lactate. The patient with D-lactic acidosis had a 10-fold increased DL-lactate production from glucose in fecal homogenates compared to 14 healthy controls and a patient with intestinal bypass, who did not have D-lactic acidosis. A 67% carbohydrate (starch)-enriched diet resulted in a minor elevation of fecal and plasma lactate, whereas 50 + 100 + 150 g of ingested lactose increased D-lactate in feces (84.0 mmol/liter) and plasma (2.3 mmol/liter) considerably in the patient with D-lactic acidosis. Intestinal prolongation (22 cm ileum) had a temporary effect on fecal and plasma D-lactate, but intestinal continuity was reestablished 26 months later because D-lactic acidosis recurred (plasma 8.6 mmol/liter, urine 101.3 mmol/liter). Large amounts of lactulose (160 g/day) to 12 normal individuals increased D-lactate to 13.6 +/- 3.5 mmol/liter in feces, but never increased D-lactate in plasma or urine. The in vitro fermentation of glucose in fecal homogenates increased DL-lactate, which disappeared after complete metabolization of the glucose. L-Lactate was converted to D-lactate and vice versa, and both were degraded to the short-chain fatty acids acetate, propionate, and butyrate. An infrequent, but elevated ability of the colonic flora to produce lactate may be a prerequisite for D-lactic acidosis to occur and may explain why the syndrome is so seldom seen even in patients with intestinal bypass or short bowels. The suggestion that D-lactate is not metabolized and hence accumulates is probably not valid.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851197     DOI: 10.1007/bf02065417

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

1.  Diarrhoea caused by deficiency of sugar splitting enzymes. I.

Authors:  H A WEIJERS; J H va de KAMER; W K DICKE; J IJSSELING
Journal:  Acta Paediatr       Date:  1961-01       Impact factor: 2.299

2.  Pretreatment methods prior to gaschromatographic analysis of volatile fatty acids from faecal samples.

Authors:  J B Zijlstra; J Beukema; B G Wolthers; B M Byrne; A Groen; J Dankert
Journal:  Clin Chim Acta       Date:  1977-07-15       Impact factor: 3.786

3.  D-lactic acidosis of ruminants.

Authors:  R H Dunlop; P B Hammond
Journal:  Ann N Y Acad Sci       Date:  1965-07-31       Impact factor: 5.691

4.  An unusual cause of D-lactic acidosis.

Authors:  C H Nghiem; H D Bui; R H Chaney
Journal:  West J Med       Date:  1988-03

5.  D-lactic acidosis and other complications of intestinal bypass surgery.

Authors:  J Halverson; A Gale; C Lazarus
Journal:  Arch Intern Med       Date:  1984-02

6.  The influence of ispaghula husk and lactulose on the in vivo and the in vitro production capacity of short-chain fatty acids in humans.

Authors:  H S Rasmussen; K Holtug; J R Andersen; E Krag; P B Mortensen
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

7.  Metabolic utilization and renal handling of D-lactate in men.

Authors:  M S Oh; J Uribarri; D Alveranga; I Lazar; N Bazilinski; H J Carroll
Journal:  Metabolism       Date:  1985-07       Impact factor: 8.694

8.  D-Lactic acidosis in children: an unusual metabolic complication of small bowel resection.

Authors:  D H Perlmutter; J T Boyle; J M Campos; J M Egler; J B Watkins
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

9.  D-Lactic acidosis in a boy with short bowel syndrome.

Authors:  E P Schoorel; M A Giesberts; W Blom; H H van Gelderen
Journal:  Arch Dis Child       Date:  1980-10       Impact factor: 3.791

10.  D-lactate encephalopathy.

Authors:  J R Thurn; G L Pierpont; C W Ludvigsen; J H Eckfeldt
Journal:  Am J Med       Date:  1985-12       Impact factor: 4.965

View more
  28 in total

Review 1.  Lactulose, disaccharides and colonic flora. Clinical consequences.

Authors:  M R Clausen; P B Mortensen
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

2.  Impact of the metabolic activity of Streptococcus thermophilus on the colon epithelium of gnotobiotic rats.

Authors:  Françoise Rul; Leila Ben-Yahia; Fatima Chegdani; Laura Wrzosek; Stéphane Thomas; Marie-Louise Noordine; Christophe Gitton; Claire Cherbuy; Philippe Langella; Muriel Thomas
Journal:  J Biol Chem       Date:  2011-01-14       Impact factor: 5.157

3.  Isolation and characterization of two new homoacetogenic hydrogen-utilizing bacteria from the human intestinal tract that are closely related to Clostridium coccoides.

Authors:  B Kamlage; B Gruhl; M Blaut
Journal:  Appl Environ Microbiol       Date:  1997-05       Impact factor: 4.792

4.  Abnormal fecal flora in a patient with short bowel syndrome. An in vitro study on effect of pH on D-lactic acid production.

Authors:  M I Caldarini; S Pons; D D'Agostino; J A DePaula; G Greco; G Negri; A Ascione; D Bustos
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

5.  Effect of L-lactic acid, short-chain fatty acids, and pH in cecal infusate on morphometric and cell kinetic parameters of rat cecum.

Authors:  H Ichikawa; T Sakata
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

6.  Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels.

Authors:  Jeffrey H Burton; Matthew Johnson; Jolene Johnson; Daniel S Hsia; Frank L Greenway; Mark L Heiman
Journal:  J Diabetes Sci Technol       Date:  2015-03-23

7.  Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production.

Authors:  T Jiang; D A Savaiano
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

Review 8.  Safety assessment of probiotics for human use.

Authors:  Mary Ellen Sanders; Louis M A Akkermans; Dirk Haller; Cathy Hammerman; James Heimbach; Gabriele Hörmannsperger; Geert Huys; Dan D Levy; Femke Lutgendorff; David Mack; Phoukham Phothirath; Gloria Solano-Aguilar; Elaine Vaughan
Journal:  Gut Microbes       Date:  2010-03-04

9.  Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate.

Authors:  M R Clausen; J Jørgensen; P B Mortensen
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

10.  Gastric PgCO2 and Pg-aCO2 gap are related to D-lactate and not to L-lactate levels in patients with septic shock.

Authors:  Martijn Poeze; Barbara C J Solberg; Jan Willem M Greve; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-10-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.